Medicine
Betamethasone valerate 0.12% foam
Betamethasone valerate 0.12% foam is a generic prescription medicine for topical use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Betamethasone valerate
- Brand
- Sold under the generic name
- Strength
- 0.12%
- Dosage form
- Foam
- Route
- Topical
- Packs
- 1 can, 1 canister and 7 more
- Manufacturers
- Alembic PharmaceuticalsIndiaSun Pharmaceutical IndustriesIndiaPadagis Israel PharmaceuticalsXiromed
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 January 2013
- Identifiers
- RxCUI 1244634DailyMed set ID 7c96b978-25ff-44c2-bc9c-30ff5e34cffb, dc5dfd3e-7762-40c8-880e-c7db80d87749, dee8f6d1-b0ba-3c56-f08d-eb6283b0b250 +2NDC 51672-4188, 45802-053, 70700-141 +2Application ANDA208204, ANDA078337, ANDA210639 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 can in 1 carton / 100 g in 1 can | 46708-708-31 | Alembic PharmaceuticalsIndia | 22 August 2024 |
| 1 can in 1 carton / 50 g in 1 can | 46708-708-50 | Alembic PharmaceuticalsIndia | 22 August 2024 |
| 1 can in 1 carton / 100 g in 1 can | 62332-708-31 | Alembic PharmaceuticalsIndia | 22 August 2024 |
| 1 can in 1 carton / 50 g in 1 can | 62332-708-50 | Alembic PharmaceuticalsIndia | 22 August 2024 |
| 1 can in 1 carton / 50 g in 1 can | 51672-4188-3 | Sun Pharmaceutical IndustriesIndia | 24 May 2017 |
| 1 can in 1 carton / 100 g in 1 can | 51672-4188-7 | Sun Pharmaceutical IndustriesIndia | 24 May 2017 |
| 1 can in 1 carton / 50 g in 1 can | 45802-053-01 | Padagis Israel Pharmaceuticals | 15 January 2013 |
| 1 can in 1 carton / 100 g in 1 can | 45802-053-02 | Padagis Israel Pharmaceuticals | 15 January 2013 |
| 1 canister in 1 carton / 50 g in 1 canister | 70700-141-19 | Xiromed | 10 May 2023 |
| 1 canister in 1 carton / 100 g in 1 canister | 70700-141-20 | Xiromed | 10 May 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 2 September 1967 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Betamethasone valerate
Clinical summary
Betamethasone valerate is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. It is available as cream, foam and ointment for topical use. MedsAcross supplies Betamethasone valerate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Betamethasone valerateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Betamethasone Valerate prescribing information (Cosette Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Betamethasone valerate 0.12% foam for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.